Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 6/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.40 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.40 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | KDM4A | O75164 | 1/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Decoquinate SCHEMBL29373625 | 1.00 | DPP4 (0.46) | DPP4ESR1NPC1LMNARAB9A | |
| Decoquinate SCHEMBL14247781 | 0.98 | DPP4 (0.44) | DPP4ESR1NPC1LMNARAB9A | |
| Decoquinate SCHEMBL14247780 | 0.97 | DPP4 (0.44) | DPP4ESR1NPC1LMNARAB9A | |
| Decoquinate SCHEMBL10696854 | 0.95 | DPP4 (0.42) | DPP4ESR1NPC1LMNARAB9A | |
| Decoquinate SCHEMBL15152849 | 0.89 | LMNA (0.47) | DPP4NPC1LMNARAB9AHSD17B10 | |
| SCHEMBL7071545 | 0.88 | PTPN11 (0.45) | HSD17B10 | |
| SCHEMBL28319922 | 0.86 | DPP4 (0.61) | DPP4LMNARAB9A | |
| SCHEMBL27768228 | 0.84 | PTPN11 (0.45) | NPC1LMNARAB9AHSD17B10KDM4E | |
| SCHEMBL29409636 | 0.83 | DPP4 (0.53) | DPP4 | |
| SCHEMBL22589588 | 0.83 | DPP4 (0.53) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5704 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12564571-B2 | Compositions and methods for the treatment of equine protozoal myeloencephalitis | GOING BIG TIME INC (US) | 2026-03-03 | — | — | US | claimed |
| WO-2025151711-A1 | NUCLEIC ACID VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025151713-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | claimed |
| US-20250222082-A1 | PROTEIN AND PEPTIDE VACCINES TARGETING METHANOGENS | ARKEA BIO CORP (US) | 2025-07-10 | — | — | US | claimed |
| WO-2025128700-A1 | CELL-BASED VACCINES | Arkea Bio Corp. (US) | 2025-06-19 | — | — | WO | claimed |
| WO-2025085377-A1 | USE OF ZOALENE IN LIVESTOCK | ZOETIS SERVICES LLC (US) | 2025-04-24 | — | — | WO | claimed |
| CN-119606968-A | Composite preparation of embedded decoquinate and preparation method thereof | 浙江汇能生物股份有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119157887-A | Does not contain ethanol or iso propanol calcipotriol composition | 江苏知原药业股份有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-119015233-A | Preparation method of decoquinate nano powder, product and application thereof | 山东德州神牛药业有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-118724807-B | Decoquinate hapten, antigen, antibody and preparation and application thereof | 广州科技贸易职业学院 | 2024-11-15 | — | — | CN | claimed |
| WO-1994024886-A1 | COMPOSITIONS FOR ADMINISTRATION TO ANIMALS WITH COCCIDIOSIS | CULTOR LTD. (FI) | 1994-11-10 | — | — | WO | claimed |
| US-5209866-A | HETEROCYCLIC 1,2-DIFLUOROBENZENE DERIVATIVES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1993-05-11 | — | — | US | claimed |
| US-5200418-A | Orally administering decoquinate to neonatal bovine exposed and susceptivle to infection by cryptosporidium oocysts | THE OHIO STATE UNIVERSITY (US) | 1993-04-06 | — | — | US | claimed |
| EP-0107759-B1 | CYCLOHEXANE DERIVATIVES AND THEIR USE AS COMPONENTS FOR LIQUID CRYSTALS | MERCK PATENT GmbH (DE) | 1992-12-16 | — | — | EP | claimed |
| US-5043093-A | Liquid crystals | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1991-08-27 | — | — | US | claimed |
| EP-0227717-B1 | NITROGEN-CONTAINING HETEROCYCLIC ESTERS | MERCK PATENT GmbH (DE) | 1990-04-25 | — | — | EP | claimed |
| US-4882082-A | PYRIMIDINE DERIVATIVE LIQUID CRYSTALS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1989-11-21 | — | — | US | claimed |
| US-4820839-A | LIQUID CRYSTALS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1989-04-11 | — | — | US | claimed |
| US-4195089-A | Synergistic composition for malaria | BURROUGHS WELLCOME CO. (US) | 1980-03-25 | — | — | US | claimed |
| US-4085141-A | Process for the preparation of anilines meta-substituted by chlorine | BAYER AKTIENGESELLSCHAFT (DT) | 1978-04-18 | — | — | US | claimed |